Cronos Group Inc. (CRON) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CRON Revenue Growth
Revenue Breakdown (FY 2025)
CRON's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CRON Revenue Analysis (2014–2025)
As of May 8, 2026, Cronos Group Inc. (CRON) generated trailing twelve-month (TTM) revenue of $193.4 million, reflecting explosive growth of +201.3% year-over-year. The most recent quarter (Q4 2025) recorded $91.3 million in revenue, up 151.3% sequentially.
Looking at the longer-term picture, CRON's 5-year compound annual growth rate (CAGR) stands at +32.9%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $193.4 million in 2025, representing a new all-time high.
Revenue diversification analysis shows CRON's business is primarily driven by Cannabis Flower (74%), Cannabis Extracts (26%), and Product and Service, Other (0%). With over half of revenue concentrated in Cannabis Flower, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CGC (+6.3% YoY), TLRY (+3.0% YoY), and ACB (+12.8% YoY), CRON has outperformed the peer group in terms of revenue growth. Compare CRON vs CGC →
CRON Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CRONCurrent | $193M | +201.3% | +32.9% | -1.5% | |
 CGC | $269M | +6.3% | -7.6% | -43.5% | |
 TLRY | $1.1B | +3.0% | +22.7% | -277.9% | |
 ACB | $343M | +12.8% | +5.0% | 1.4% | |
 IIPR | $266M | -13.6% | +17.9% | 46.7% | |
 SMG | $3.4B | -5.9% | -3.7% | 10.5% |
CRON Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $193.4M | +64.4% | $62.8M | 32.5% | $-2,929,000 | -1.5% |
| 2024 | $117.6M | +34.8% | $25.2M | 21.4% | $-76,529,000 | -65.1% |
| 2023 | $87.2M | +0.6% | $11.9M | 13.7% | $-84,800,000 | -97.2% |
| 2022 | $86.7M | +34.4% | $15.4M | 17.8% | $-111,428,000 | -128.4% |
| 2021 | $64.6M | +38.2% | $-17,593,000 | -27.3% | $-291,969,000 | -452.2% |
| 2020 | $46.7M | +96.7% | $-25,833,000 | -55.3% | $-219,387,000 | -469.6% |
| 2019 | $23.8M | +95.9% | $-17,597,000 | -74.1% | $-153,316,000 | -645.5% |
| 2018 | $12.1M | +273.4% | $6.2M | 51.3% | $-20,445,000 | -168.7% |
| 2017 | $3.2M | +687.2% | $1.3M | 39.1% | $-6,121,000 | -188.6% |
| 2016 | $412K | -87.9% | $1.5M | 359.7% | $-1,225,000 | -297.1% |
See CRON's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRON Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRON vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRON — Frequently Asked Questions
Quick answers to the most common questions about buying CRON stock.
Is CRON's revenue growth accelerating or slowing?
CRON revenue is accelerating at +201.3% year-over-year, exceeding the 5-year CAGR of +32.9%. TTM revenue reached $193M. Growth momentum has increased versus prior periods.
What is CRON's long-term revenue growth rate?
Cronos Group Inc.'s 5-year revenue CAGR of +32.9% reflects the sustained expansion pattern. Current YoY growth of +201.3% is above this long-term average.
How is CRON's revenue distributed by segment?
CRON reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.